You are researching: Veterans Administration Medical Center
Matching entries: 1 /1
All Groups
AUTHOR Lagatuz, M. and Vyas, R. J. and Predovic, M. and Lim, S. and Jacobs, N. and Martinho, M. and Valizadegan, H. and Kao, D. and Oza, N. and Theriot, C. A. and Zanello, S. B. and Taibbi, G. and Vizzeri, G. and Dupont, M. and Grant, M. B. and Lindner, D. J. and Reinecker, H.-C. and Pinhas, A. and Chui, T. Y. and Rosen, R. B. and Moldovan, N. and Vickerman, M. B. and Radhakrishnan, K. and Parsons-Wingerter, P.
Title Vascular Patterning as Integrative Readout of Complex Molecular and Physiological Signaling by VESsel GENeration Analysis [Abstract]
Year 2021
Journal/Proceedings J Vasc Res
The molecular signaling cascades that regulate angiogenesis and microvascular remodeling are fundamental to normal development, healthy physiology, and pathologies such as inflammation and cancer. Yet quantifying such complex, fractally branching vascular patterns remains difficult. We review application of NASA’s globally available, freely downloadable VESsel GENeration (VESGEN) Analysis software to numerous examples of 2D vascular trees, networks, and tree-network composites. Upon input of a binary vascular image, automated output includes informative vascular maps and quantification of parameters such as tortuosity, fractal dimension, vessel diameter, area, length, number, and branch point. Previous research has demonstrated that cytokines and therapeutics such as vascular endothelial growth factor, basic fibroblast growth factor (fibroblast growth factor-2), transforming growth factor-beta-1, and steroid triamcinolone acetonide specify unique “fingerprint” or “biomarker” vascular patterns that integrate dominant signaling with physiological response. In vivo experimental examples described here include vascular response to keratinocyte growth factor, a novel vessel tortuosity factor; angiogenic inhibition in humanized tumor xenografts by the anti-angiogenesis drug leronlimab; intestinal vascular inflammation with probiotic protection by Saccharomyces boulardii, and a workflow programming of vascular architecture for 3D bioprinting of regenerative tissues from 2D images. Microvascular remodeling in the human retina is described for astronaut risks in microgravity, vessel tortuosity in diabetic retinopathy, and venous occlusive disease.